Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Liposomal Doxorubicin (Doxil)
DRUG
2 trials
Sponsors
Case Comprehensive Cancer Center
, Fudan University
Conditions
Dedifferentiated Liposarcoma
Relapsed Sarcomas
Soft Tissue Sarcoma (STS)
Phase 1
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Recruiting
NCT05210374
Case Comprehensive Cancer Center
Relapsed Sarcomas
Start: 2023-03-09
End: 2026-12-31
Target: 24
Updated: 2026-08-06
Phase 2
First-line Treatment of Advanced/unresectable DDLPS
Not yet recruiting
NCT06694324
Fudan University
Dedifferentiated Liposarcoma, Soft Tissue Sarcoma (STS)
Start: 2024-12-01
End: 2026-12-01
Target: 49
Updated: 2024-11-19
Related Papers
Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227.
2022-11-15
6 citations